Clinical Trial

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Completed
View on ClinicalTrials.gov →
Summary
When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-12
notable Primary completion moved earlier: 2026-07 -> 2026-04-29 2026-08-12
minor Completion moved earlier: 2026-07 -> 2026-04-29 2026-08-12
Trial Details
NCT Number NCT06382207
Lead Sponsor Virginia Commonwealth University
Collaborators: Eko Devices, Inc.
Conditions Tachyarrhythmia
Enrollment 91 participants
Start Date 2025-01-17
Primary Completion 2026-04-29 (estimated)
Study Completion 2026-04-29 (estimated)
Updated on ClinicalTrials.gov 2026-08-11